Patheon to Showcase Non-Sterile, Sterile and Softgel Capabilities at CPhI/ICSE
Complete the form below to unlock access to ALL audio articles.
Patheon Inc. will showcase its offerings, including non-sterile, sterile and softgel dose forms at CPhI/ICSE in Messe Frankfurt, Germany, Oct. 22-24, 2013.
Patheon’s Harry Gill, senior vice president, quality and continuous improvement, will present “Utilizing Operational Excellence Principles to Drive Quality Improvements” on Wednesday, Oct. 23 at 2:30 p.m. CET in Hall 4.2 Booth L52.
During the presentation, Gill will discuss how the company’s Patheon Advantage II program has been one of the main drivers of its efficiency improvement efforts.
Patheon has utilized these same philosophies to create improvements in its quality performance, in particular Right First Time, which is a key performance indicator for both Patheon and its clients.
In addition, many Patheon executives, technical and scientific experts will also attend CPhI/ICSE and will be available to discuss Patheon’s non-sterile, sterile and softgel capabilities for development and commercial.
Patheon’s experience encompasses thousands of projects for pharmaceutical and biotechnology companies of all types and sizes.
The company gives access to the expertise, proven quality and global resources to bring drug candidates from preclinical stages through commercial production.
Patheon will be exhibiting at Hall 4.2, Booth 42G03 for the duration of the conference.
